Avalon Ventures Portfolio 2026

12 companies backed by Avalon Ventures, including AristaMD, Joy, Vocera Communications. Each links to its full verified cap-table syndicate.

Avalon Ventures accounts for 11 tracked companies with verified cap-table data, 11 of which disclose round sizes totalling $691M. The median disclosed raise is $56M, and the largest is Joy at $108M, ahead of OncXerna Therapeutics ($97M) and Otonomy ($94M).

The names that recur most often on these portfolio cap tables are Avalon Ventures (11 companies), OrbiMed (2 companies), Osage University Partners (2 companies), Polaris Partners (2 companies), Versant Ventures (2 companies), AbbVie Ventures (2 companies). By latest disclosed round, the market skews Series B (4), Series A (3), Series C (2), Series D (1).

Best funded Avalon Ventures companies

  1. Joy — $108M (latest: Series B)
  2. OncXerna Therapeutics — $97M (latest: Series B)
  3. Otonomy — $94M (latest: Series D)
  4. Skycatch — $75M (latest: Series B)
  5. Arialys Therapeutics — $58M (latest: Seed)
  6. Janux Therapeutics — $56M (latest: Series A)
  7. Jnana Therapeutics — $50M (latest: Series A)
  8. Jnana — $50M (latest: Series C)
  9. Orion Labs — $43M (latest: Series B)
  10. Fortis Therapeutics — $40M (latest: Series A)
  11. AristaMD — $20M (latest: Series C)

Avalon Ventures — related firms and companies (55)

Avalon Ventures profile · All research reports